Valérie Philippon shares her perspectives on the value of including data beyond those generated in clinical trials in publication plans.
Read about the upcoming NIH requirement to include a data management and sharing plan in all grant applications for projects collecting scientific data.
Learn about the importance of short communications in scientific publishing and the potential impact of their decline.
Braydon McCormick and Mark Handforth discuss collecting meaningful data about meetings.
Find out why journals are planning to ask authors, reviewers, and editors about their gender, race, and ethnicity.
Antonia Trent and James Atherton discuss recent changes in the HCP engagement landscape.
Learn about a new decision support tool developed to supplement the ICMJE criteria and GPP3 guidelines.
Read about Cochrane reviewers’ approaches to detecting and tackling potential fraud in clinical trial publications.
Join us at the 10th EMWA Symposium: “Communicating with the public – what has the COVID-19 pandemic taught us?”
The 10th EMWA Symposium will take place on 5 May, 2022. Register now!
Read about the proposed actions to increase social justice in scientific publishing.
Springer Nature’s Chief Publishing Officer provides an insight into the transition to open access publishing following their publication of 1 million open access articles.
Find out patient preferences for the format and complexity of plain language summaries.
Get up to date with the growing fraudulent impersonation problem hitting journals publishing special issues.
Find out the long-term effects of the COVID-19 pandemic on the scientific community.
Read about the pros and cons of disclosing reviewer identities as part of the open review process.
Preprints have changed the way that authors can receive feedback on their manuscript; but when does it verge on ‘unethical’ duplicate peer review?